Results

RDF/XMLNTriplesTurtleShow queryShare ▶
SubjectPredicateObject
http://purl.uniprot.org/citations/37013511http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/37013511http://www.w3.org/2000/01/rdf-schema#comment"

Background

Nonerythrocytic spectrin beta 1 (SPTBN1) is an important cytoskeletal protein that involves in normal cell growth and development via regulating TGFβ/Smad signaling pathway, and is aberrantly expressed in various cancer types. But, the exact role of SPTBN1 in pan-cancer is still unclear. This report aimed to display expression patterns and prognostic landscapes of SPTBN1 in human cancers, and further assess its prognostic/therapeutic value and immunological role in kidney renal carcinoma (KIRC) and uveal melanoma (UVM).

Methods

We firstly analyzed expression patterns and prognostic landscapes of SPTBN1 in human cancers using various databases and web-based tools. The relationships between SPTBN1 expression and survival/tumor immunity in KIRC and UVM were further investigated via R packages and TIMER 2.0 platform. The therapeutic roles of SPTBN1 in KIRC and UVM were also explored via R software. Following this, the prognostic value and cancer immunological role of SPTBN1 in KIRC and UVM were validated in our cancer patients and GEO database.

Results

Overall, cancer tissue had a lower expression level of SPTBN1 frequently in pan-cancer, compared with those in adjacent nontumor one. SPTBN1 expression often showed a different effect on survival in pan-cancer; upregulation of SPTBN1 was protective to the survival of KIRC individuals, which was contrary from what was found in UVM patients. In KIRC, there were significant negative associations between SPTBN1 expression and pro-tumor immune cell infiltration, including Treg cell, Th2 cell, monocyte and M2-macrophage, and expression of immune modulator genes, such as tumor necrosis factor superfamily member 9 (TNFSF9); while, in UVM, these correlations exhibited opposite patterns. The following survival and expression correlation analysis in our cancer cohorts and GEO database confirmed these previous findings. Moreover, we also found that SPTBN1 was potentially involved in the resistance of immunotherapy in KIRC, and the enhance of anti-cancer targeted treatment in UVM.

Conclusions

The current study presented compelling evidence that SPTBN1 might be a novel prognostic and therapy-related biomarker in KIRC and UVM, shedding new light on anti-cancer strategy."xsd:string
http://purl.uniprot.org/citations/37013511http://purl.org/dc/terms/identifier"doi:10.1186/s12885-023-10789-3"xsd:string
http://purl.uniprot.org/citations/37013511http://purl.uniprot.org/core/author"He Z."xsd:string
http://purl.uniprot.org/citations/37013511http://purl.uniprot.org/core/author"Li X."xsd:string
http://purl.uniprot.org/citations/37013511http://purl.uniprot.org/core/author"Zhang X."xsd:string
http://purl.uniprot.org/citations/37013511http://purl.uniprot.org/core/author"Tang W."xsd:string
http://purl.uniprot.org/citations/37013511http://purl.uniprot.org/core/author"Shao Q."xsd:string
http://purl.uniprot.org/citations/37013511http://purl.uniprot.org/core/author"Wu R."xsd:string
http://purl.uniprot.org/citations/37013511http://purl.uniprot.org/core/date"2023"xsd:gYear
http://purl.uniprot.org/citations/37013511http://purl.uniprot.org/core/name"BMC Cancer"xsd:string
http://purl.uniprot.org/citations/37013511http://purl.uniprot.org/core/pages"303"xsd:string
http://purl.uniprot.org/citations/37013511http://purl.uniprot.org/core/title"Clinical significance of nonerythrocytic spectrin Beta 1 (SPTBN1) in human kidney renal clear cell carcinoma and uveal melanoma: a study based on Pan-Cancer Analysis."xsd:string
http://purl.uniprot.org/citations/37013511http://purl.uniprot.org/core/volume"23"xsd:string
http://purl.uniprot.org/citations/37013511http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/37013511
http://purl.uniprot.org/citations/37013511http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/37013511
http://purl.uniprot.org/uniprot/#_B2ZZ89-mappedCitation-37013511http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/37013511
http://purl.uniprot.org/uniprot/#_B4DIF8-mappedCitation-37013511http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/37013511
http://purl.uniprot.org/uniprot/#_Q53RC4-mappedCitation-37013511http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/37013511
http://purl.uniprot.org/uniprot/#_K9MS24-mappedCitation-37013511http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/37013511
http://purl.uniprot.org/uniprot/#_Q01082-mappedCitation-37013511http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/37013511
http://purl.uniprot.org/uniprot/#_Q59FA9-mappedCitation-37013511http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/37013511
http://purl.uniprot.org/uniprot/#_Q8WYB3-mappedCitation-37013511http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/37013511
http://purl.uniprot.org/uniprot/K9MS24http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/37013511
http://purl.uniprot.org/uniprot/Q8WYB3http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/37013511
▶